Literature DB >> 7793228

Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia.

P K Mölsä1, R J Marttila, U K Rinne.   

Abstract

Long-term survival was examined for 218 patients with Alzheimer's disease (AD) and 115 patients with multi-infarct dementia (MID). The 14-year survival rate for AD was 2.4% versus an expected rate of 16.6%, and for MID 1.7% versus 13.3% expected. MID showed a more malignant natural course than AD. Men carried a less favourable survival prognosis than women, both in AD and MID: the relative risk of dying for women was half that for men in both diseases. In MID, advanced disability indicated a relative risk of dying over twice as high. In both diseases the risk of death was substantially higher in the event of occurrence of primitive reflexes.

Entities:  

Mesh：

Year:  1995        PMID： 7793228     DOI： 10.1111/j.1600-0404.1995.tb00426.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


  28 in total

1.  A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.

Authors:  Ruth Peters; Nigel Beckett; Maria Nunes; Astrid Fletcher; Françoise Forette; Christopher Bulpitt
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 3.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Deaths attributable to Alzheimer's disease in the United States.

Authors:  D C Ewbank
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

Review 5.  Alzheimer disease immunotherapeutics: then and now.

Authors:  Harashish Jindal; Bhumika Bhatt; Shashikantha Sk; Jagbir Singh Malik
Journal:  Hum Vaccin Immunother       Date:  2014-10-31       Impact factor: 3.452

6.  Survival in Alzheimer disease: a multiethnic, population-based study of incident cases.

Authors:  E P Helzner; N Scarmeas; S Cosentino; M X Tang; N Schupf; Y Stern
Journal:  Neurology       Date:  2008-11-04       Impact factor: 9.910

7.  Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.

Authors:  Xingbin Wang; Oscar Lopez; Robert A Sweet; James T Becker; Steven T DeKosky; Mahmud M Barmada; Eleanor Feingold; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  [Impact of vascular pathology on survival times of 173 dementia patients--Hachinski's ischemic score as a predictive tool for clinical purposes].

Authors:  S Kissler; S D Hötte; D Lankers; G Juckel; S G Schröder
Journal:  Z Gerontol Geriatr       Date:  2008-02       Impact factor: 1.281

9.  Race/ethnic differences in AD survival in US Alzheimer's Disease Centers.

Authors:  K M Mehta; K Yaffe; E J Pérez-Stable; A Stewart; D Barnes; B F Kurland; B L Miller
Journal:  Neurology       Date:  2007-11-14       Impact factor: 9.910

10.  Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.

Authors:  María M Corrada; Annlia Paganini-Hill; Daniel J Berlau; Claudia H Kawas
Journal:  Alzheimers Dement       Date:  2012-11-02       Impact factor: 21.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.